RESTON, Va., July 9, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a Fortune® 500 innovation company, has been awarded the Medicaid Enterprise Systems Integrator contract by North Dakota Health and Human Services. Leidos will provide systems integration support to transition North Dakota's existing Medicaid Management Information Systems to an integrated, scalable, and secure modular system. Leidos is a Fortune 500 (r) innovation company. (PRNewsFoto/Leidos) "Transitioning North Dakota's legacy Medicaid systems to a modern system will help provide a better healthcare experience for patients, providers and administrators," said Liz Porter, Leidos Health & Civil Sector President. "Building on our strength of innovation and proven expertise in technology modernization, we look forward to delivering tailored solutions that empower data-driven decision making. This modernization project will help position North Dakota to embrace and harness future advancements." Leidos will support North Dakota's goals of improving health outcomes and ensuring efficient, effective, and economical management of its Medicaid program through Medicaid Enterprise Systems (MES) modernization. MES involves a comprehensive set of technologies and solutions that manage and administer benefits in compliance with federal and state regulations. Leidos will collaborate with North Dakota Health and Human Services to meet the unique challenges of modernizing MES, optimizing data management, ensuring interoperability, and executing seamless transition. To learn more, read about Leidos' Medicaid systems solutions or visit www.leidos.com/civilian-health. About Leidos Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 47,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $15.4 billion for the fiscal year ended December 29, 2023. For more information, visit www.leidos.com. Certain statements in this announcement constitute "forward-looking statements" within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management's current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the "Risk Factors" set forth in Leidos' Annual Report on Form 10-K for the fiscal year ended December 29, 2023, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made. Contact: Melissa Dueñas (571) 526-6850 [email protected] Alyssa Pettus (571) 526-6743 [email protected] Brandon Ver Velde (571) 526-6257 [email protected] Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/leidos-awarded-medicaid-enterprise-systems-integrator-contract-302191078.html SOURCE Leidos Holdings, Inc.
Leidos awarded Medicaid Enterprise Systems Integrator contract
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...